Cargando…
Chronic Myeloid Leukemia With Rare Variant b2a3 (e13a3) BCR-ABL1 Fusion
Autores principales: | Ha, Jihye, Cheong, June-Won, Shin, Saeam, Lee, Seung-Tae, Choi, Jong Rak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Laboratory Medicine
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773277/ https://www.ncbi.nlm.nih.gov/pubmed/26915625 http://dx.doi.org/10.3343/alm.2016.36.3.287 |
Ejemplares similares
-
Development and validation of sensitive BCR::ABL1 fusion gene quantitation using next-generation sequencing
por: Lee, Hyeonah, et al.
Publicado: (2023) -
Characteristics of BCR–ABL gene variants in patients of chronic myeloid leukemia
por: Amin, Huma, et al.
Publicado: (2021) -
Pharmacogenetics of BCR/ABL Inhibitors in Chronic Myeloid Leukemia
por: Polillo, Marialuisa, et al.
Publicado: (2015) -
Chronic myeloid leukemia with an e1a3 BCR-ABL fusion protein: transformation to lymphoid blast crisis
por: Martinez-Serra, Jordi, et al.
Publicado: (2014) -
Philadelphia Chromosome-positive Acute Myeloid Leukemia With e1a3 BCR-ABL1 Fusion Transcript
por: Sheets, Julia W., et al.
Publicado: (2020)